Arvaya HealthcareBOM:524723 34 Net Margin % is 13.89% as of Mar. 2026. GuruFocus rates BOM:524723 with a GF Score™ of 34/100 and a GF Value™ of ₹48.97 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 117 Medical Distribution companies, Arvaya Healthcare ranks better than 82.05% on this metric.
The historical rank and industry rank for Arvaya Healthcare's Net Margin % or its related term are showing as below:
BOM:524723'
s Net Margin % Range Over the Past 10 Years
Min: -148.23 Med: -21.15 Max: 48.8
Current: 5.94
BOM:524723's Net Margin % is ranked better than 82.05% of 117
companies
in the Medical Distribution industry
Industry Median: 1.5
vs BOM:524723: 5.94
Arvaya Healthcare (BOM:524723) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Arvaya Healthcare Net Margin % Related Terms
Arvaya Healthcare Net Margin % Historical Data
* Premium members only.
The historical data trend for Arvaya Healthcare's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524723 vs MCK, CAH, COR: Net Margin % Comparison
For the Medical Distribution subindustry, Arvaya Healthcare's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arvaya Healthcare Net Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Arvaya Healthcare's Net Margin % distribution charts can be found below:
* The bar in red indicates where Arvaya Healthcare's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arvaya Healthcare (BOM:524723) has a Net Margin % of 13.89% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Arvaya Healthcare and its competitors. According to the industry distribution chart, Arvaya Healthcare ranks #21 out of 117 companies in the Medical Distribution industry, placing it in the top 17.9%.
Is Arvaya Healthcare's Net Margin % too high?
Arvaya Healthcare's current Net Margin % is 13.89%. The Medical Distribution industry median Net Margin % is 1.50. Arvaya Healthcare's value of 13.89% is 826% above this industry median. Based on the distribution chart, Arvaya Healthcare ranks #21 out of 117 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Arvaya Healthcare has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Arvaya Healthcare's Net Margin % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Arvaya Healthcare ranks #21 out of 117 companies for Net Margin %. This places Arvaya Healthcare in the top 18% of its industry — outperforming the majority of peers. The industry median Net Margin % is 1.50. Arvaya Healthcare's value of 13.89% is 826% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Distribution company?
The median Net Margin % among Medical Distribution companies is 1.50, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arvaya Healthcare's current Net Margin % of 13.89% is 826% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Arvaya Healthcare and its competitors. For the Medical Distribution industry, the median Net Margin % is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arvaya Healthcare's current Net Margin % is 13.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arvaya Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Arvaya Healthcare (BOM:524723) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹48.97, compared to a current price of ₹67.11 — trading 37% above its estimated fair value. The current Net Margin % is 13.89% and 826% above the Medical Distribution industry median of 1.50. Arvaya Healthcare's overall GF Score™ is 34/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Arvaya Healthcare (BOM:524723), the current Net Margin % is 13.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arvaya Healthcare (BOM:524723) Overvalued in 2026?
Based on GuruFocus' analysis, Arvaya Healthcare stock appears to be overvalued.
The current stock price of ₹67.11 is trading 37% above its estimated GF Value™ of ₹48.97.
GuruFocus considers Arvaya Healthcare to be Significantly Overvalued.
Key valuation signals for BOM:524723:
Net Margin %: 13.89%
GF Value™: ₹48.97 vs. price of ₹67.11 (37% above fair value)
Industry Position: 826% above the Medical Distribution median (#21 of 117)
No single metric tells the full story. See the BOM:524723 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arvaya Healthcare Ltd is focused on developing an integrated healthcare platform in India that combines hospital services, diagnostics, wellness services, and digital health management solutions. Its operations include multi-specialty hospitals, a digital health platform for appointment booking and health record management, diagnostic services including laboratory testing and home sample collection, and wellness facilities offering preventive and recovery-focused programs.
34GF Score
Get the complete analysis for BOM:524723
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524723 has been successfully added to your 
